Clinical trial
Insulin Treatment in Cancer Cachexia
NCT00329615 · Göteborg University, Other · Completed
Key facts
| NCT number | NCT00329615 |
|---|---|
| Title | Insulin Treatment in Cancer Cachexia |
| Official title | Insulin Treatment in Cancer Cachexia: Effects on Survival, Metabolism and Physical Functioning. A Randomized Prospective Study. |
| Lead sponsor | Göteborg University, Other |
| Collaborators | Swedish Cancer Foundation Medical Research Council |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Cancer Cachexia |
| Intervention type | Drug |
| Interventions | Insulatard, flexpen |
| Enrollment | 135 |
| Start date | Jan 1, 2000 |
| Completion | Sep 1, 2005 |
| First posted | May 25, 2006 |
| Last update posted | Aug 21, 2009 |
| Countries | Sweden |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: